Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease.
Due to intensified research over the past decade, the Hedgehog (HH) pathway has been identified as a pivotal defect implicated in roughly 25% of all cancers. As one of the most frequent cancer worldwide, the development of Basal cell carcinoma (BCC) due to activation of the HH pathway has been convincingly demonstrated. Thus the discovery of this central tumor-promoting signalling pathway has not only revolutionized the understanding of BCC carcinogenesis but has also enabled the development of a completely novel therapeutic approach. Targeting just a few of several potential mutations, HH inhibitors such as GDC-0449 achieved already the first promising results in metastatic or locally advanced BCC. This paper summarizes the current understanding of BCC carcinogenesis and describes the current "mechanism-based" therapeutic strategies.
Department of Dermatology and Venerology, Otto-von-Guericke-University Magdeburg, Leipziger St. 44, 39120 Magdeburg, Germany.
Daniela
D
Göppner
Martin
M
Leverkus
Nat Cell Biol. 2010 Mar;12(3):299-305
20154679
Mutat Res. 2000 May 30;450(1-2):193-9
10838143
Clin Pharmacol Ther. 2010 Jun;87(6):743-7
20410878
Eur J Dermatol. 2008 Nov-Dec;18(6):677-82
18955210
Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):584-5
12815008
Cancer Sci. 2007 May;98(5):716-20
17355263
Nat Genet. 2008 Sep;40(9):1130-5
19165927
Arch Dermatol. 2007 Sep;143(9):1131-6
17875873
Science. 1998 Jun 5;280(5369):1603-7
9616123
Dermatol Clin. 1995 Jan;13(1):113-25
7712637
Mol Cancer Ther. 2008 Dec;7(12):3655-60
19074842
Int J Dermatol. 2004 Dec;43(12):865-9
15569004
Cancer Res. 2002 Dec 15;62(24):7186-9
12499255
J Am Acad Dermatol. 2004 May;50(5):722-33
15097956
Cancer Lett. 2007 Oct 8;255(2):300-6
17602833
J Invest Dermatol. 1996 Apr;106(4):673-8
8618003
Cancer Res. 2004 Oct 15;64(20):7545-52
15492281
Cell. 1996 Jun 14;85(6):841-51
8681379
J Dermatol Sci. 2002 May;29(1):1-9
12007715
Oncogene. 2008 Jun 19;27(27):3856-64
18264131
J Dtsch Dermatol Ges. 2009 Dec;7(12):1075-82; quiz 1083
19456852
J Invest Dermatol. 1991 Oct;97(4):747
1940450
Nature. 2001 May 17;411(6835):349-54
11357142
Am J Hum Genet. 2001 Apr;68(4):884-94
11254446
Nat Rev Cancer. 2008 Oct;8(10):743-54
18813320
Dermatol Surg. 2007 Apr;33(4):433-9; discussion 440
17430377
Z Haut Geschlechtskr. 1967 Mar 1;43(5):25-40
5626327
Cancer Invest. 2006 Jun-Jul;24(4):396-400
16777692
Mol Biosyst. 2010 Jan;6(1):44-54
20024066
Eur J Dermatol. 2004 Mar-Apr;14(2):96-102
15196999
Australas J Dermatol. 2003 Aug;44(3):159-66; quiz 167-8
12869039
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4216-20
8483937
Nature. 1998 Jan 1;391(6662):90-2
9422511
Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):389-402
15197337
Br J Dermatol. 2008 Jul;159(1):35-48
18593385
Br J Dermatol. 2005 Jan;152(1):43-51
15656799
Proc Soc Exp Biol Med. 1967 Nov;126(2):452-4
6079922
J Am Acad Dermatol. 2007 Oct;57(4):616-21
17610993
Int J Dermatol. 2007 Nov;46(11):1113-7
17988327
J R Soc Med. 1997 Jul;90(7):371-4
9290417
Clin Exp Dermatol. 2002 Oct;27(7):571-7
12464152
Cancer. 1994 Jan 15;73(2):328-35
8293396
Lancet Oncol. 2008 Dec;9(12):1149-56
19010733
Mutat Res. 1996 Oct 18;364(2):117-23
8879277
Mutat Res. 2005 Jul 1;574(1-2):105-11
15914210
J Biol Chem. 2004 Jan 9;279(2):1197-205
14555646
Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):957-61
9367070
Eur J Hum Genet. 2006 Oct;14(10):1136-44
16791138
J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1302-11
18624836
Nat Med. 2001 Jun;7(6):706-11
11385508
Br J Dermatol. 2002 Apr;146 Suppl 61:1-6
11966724
BMJ. 2003 Oct 4;327(7418):794-8
14525881
J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
11684447
Br J Cancer. 2004 Oct 18;91(8):1604-9
15381933
Genes Dev. 2005 Jan 15;19(2):214-23
15625189
Int J Cancer. 2006 Oct 15;119(8):1976-84
16721784
Nature. 2007 Mar 8;446(7132):145-6
17344839
JAMA. 2005 Aug 10;294(6):681-90
16091570
Transplantation. 2003 Feb 15;75(3):253-7
12589142
J Am Acad Dermatol. 2005 Sep;53(3):452-7
16112352
J Invest Dermatol. 2004 Oct;123(4):634-8
15373766
J Invest Dermatol. 2004 May;122(5):1180-7
15140221
Cell. 2007 Mar 9;128(5):853-64
17350573
Am J Epidemiol. 2005 Apr 15;161(8):748-54
15800267
Am J Vet Res. 1963 Nov;24:1164-75
14081451
N Engl J Med. 2009 Sep 17;361(12):1164-72
19726763
Trends Pharmacol Sci. 2009 Jun;30(6):303-12
19443052
Genes Dev. 2001 Dec 1;15(23):3059-87
11731473
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9255-9
11481486
Cancer Res. 2004 May 1;64(9):3009-13
15126335
Hum Mutat. 2006 Mar;27(3):215-9
16419085
Science. 1996 Jun 14;272(5268):1668-71
8658145
Cancer Res. 2002 Aug 15;62(16):4773-80
12183437
N Engl J Med. 2005 Nov 24;353(21):2262-9
16306523